Skip to main content
logo
SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany flag Germany · Delayed Price · Currency is EUR
24.40
-0.20 (-0.81%)
At close: Aug 8, 2025, 5:30 PM CET

ETR:1SXP Revenue

SCHOTT Pharma AG & Co. KGaA had revenue of 252.33M EUR in the quarter ending March 31, 2025, with 7.74% growth. This brings the company's revenue in the last twelve months to 972.81M, up 6.16% year-over-year. In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M with 6.51% growth.

Revenue (ttm)
972.81M
Revenue Growth
+6.16%
P/S Ratio
3.81
Revenue / Employee
203.09K
Employees
4,690
Market Cap
3.71B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 2024957.09M58.49M6.51%
Sep 30, 2023898.60M77.46M9.43%
Sep 30, 2022821.14M172.48M26.59%
Sep 30, 2021648.67M64.44M11.03%
Sep 30, 2020584.23M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Siemens Healthineers AG23.38B
Merck KGaA21.32B
Bayer Aktiengesellschaft46.17B
Fresenius SE & Co. KGaA22.26B
Fresenius Medical Care AG19.52B
Sartorius Aktiengesellschaft3.47B
Fielmann Group AG2.33B
Carl Zeiss Meditec AG2.18B
Revenue Rankings

SCHOTT Pharma AG & Co. KGaA News

More News